Related Experiment Videos
Reciprocal cross-talk between Nod2 and TAK1 signaling pathways
Chuan-Min Chen1, Yusong Gong, Min Zhang
1Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
The Journal of Biological Chemistry
|April 13, 2004
Summary
Transforming growth factor-beta-activated kinase 1 (TAK1) interacts with Nod2, impacting innate immune responses. Nod2 regulates TAK1 signaling, revealing a new role in Crohn's disease pathogenesis.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Mutations in Nod2's leucine-rich repeat (LRR) domain are linked to Crohn's disease.
- The precise function of Nod2 and its pathway regulation are not fully understood.
Purpose of the Study:
- To investigate the interaction between Nod2 and TAK1.
- To elucidate the role of TAK1 in Nod2-mediated NF-kappaB activation.
- To determine how Nod2 regulates the TAK1 signaling pathway.
Main Methods:
- Co-immunoprecipitation assays to assess protein interactions.
- Dominant-negative TAK1 experiments to evaluate NF-kappaB activation.
- Analysis of Nod2-TAK1 interaction in RICK-deficient cells.
- Mutational analysis of the Nod2 LRR domain.
Main Results:
- TAK1 interacts with Nod2 and is essential for Nod2-mediated NF-kappaB activation.
- Nod2 inhibits TAK1-induced NF-kappaB activation, particularly through its LRR region.
- A specific mutation (3020insC) in the LRR domain reduces Nod2's inhibitory effect on TAK1.
Conclusions:
- TAK1 plays a critical role in Nod2-mediated innate immune responses.
- Nod2 possesses a novel regulatory function over the TAK1 signaling pathway.
- These findings offer insights into Crohn's disease pathogenesis and potential therapeutic targets.